The human papillomavirus (HPV) capsid is composed of the major capsid protein L1 and the minor capsid protein L2. During entry, the HPV capsid undergoes numerous conformational changes that result in endosomal uptake and subsequent trafficking of the L2 protein in complex with the viral DNA to the trans-Golgi network. To facilitate this transport, the L2 protein harbors a number of putative motifs that, if capable of direct interaction, would interact with cytosolic host cell factors. These data imply that a portion of L2 becomes cytosolic during infection. Using a low concentration of digitonin to selectively permeabilize the plasma membrane of infected cells, we mapped the topography of the L2 protein during infection. We observed that epitopes within amino acid residues 64 to 81 and 163 to 170 and a C-terminal tag of HPV16 L2 are exposed on the cytosolic side of intracellular membranes, whereas an epitope within residues 20 to 38, which are upstream of a putative transmembrane region, is luminal. Corroborating these findings, we also found that L2 protein is sensitive to trypsin digestion during infection. These data demonstrate that the majority of the L2 protein becomes accessible on the cytosolic side of intracellular membranes in order to interact with cytosolic factors to facilitate vesicular trafficking.
IMPORTANCEIn order to complete infectious entry, nonenveloped viruses have to pass cellular membranes. This is often achieved through the viral capsid protein associating with or integrating into intracellular membrane. Here, we determine the topography of HPV L2 protein in the endocytic vesicular compartment, suggesting that L2 becomes a transmembrane protein with a short luminal portion and with the majority facing the cytosolic side for interaction with host cell transport factors.
Human papillomaviruses (HPVs) are nonenveloped DNA tumor viruses that infect the skin and mucosal epithelial cells. Infection by HPVs can induce hyper-proliferative lesions of the tissues, whereupon high-risk HPVs can progress to malignant tumors. Of the high-risk HPVs, 70% of cervical cancer can be attributed to HPVs 16 and 18 (1). These HPVs are associated with a variety of anogenital and oral carcinomas. Despite the success of the prophylactic vaccine against these high-risk HPVs, HPV-associated cancers will continue to be a global health burden in the future due to low vaccination rates and lack of therapeutic effect (2). Therefore, uncovering the conserved steps of how HPVs establish infection can be used to find antiviral targets that may be less virus restrictive than the current vaccines.The HPV capsid is composed of 360 molecules of the major capsid protein, L1, and up to 72 molecules of the minor capsid protein, L2 (3-6). Much of our advancement in understanding HPV entry can be attributed to the efficient generation of pseudovirions. With respect to cellular entry, pseudovirions are considered to be indistinguishable from native virions but encapsidate a reporter plasmid (pseudogenome) in place of the HP...